Welcome to LookChem.com Sign In|Join Free
  • or
C17H12ClNO2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

312758-85-3

Post Buying Request

312758-85-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

312758-85-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 312758-85-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,2,7,5 and 8 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 312758-85:
(8*3)+(7*1)+(6*2)+(5*7)+(4*5)+(3*8)+(2*8)+(1*5)=143
143 % 10 = 3
So 312758-85-3 is a valid CAS Registry Number.

312758-85-3Downstream Products

312758-85-3Relevant academic research and scientific papers

Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents

Upadhyay, Akanksha,Kushwaha, Pragati,Gupta, Sampa,Dodda, Ranga Prasad,Ramalingam, Karthik,Kant, Ruchir,Goyal, Neena,Sashidhara, Koneni V.

, p. 172 - 181 (2018/05/25)

The high potential of quinoline containing natural products and their derivatives in medicinal chemistry led us to discover novel series of 25 compounds for the development of new antileishmanial agents. A series of triazolyl 2-methyl-4-phenylquinoline-3-carboxylate derivatives has been synthesized via click chemistry inspired molecular hybridization approach and evaluated against Leishmania donovani. Most of the screened derivatives exhibited significant in vitro anti-leishmanial activity against promastigote (IC50 ranging from 2.43 to 45.75 μM) and intracellular amastigotes (IC50 ranging from 7.06 to 34.9 μM) than the control, miltefosine (IC50 = 8.4 μM), with less cytotoxicity in comparison to the standard drugs. Overall results revealed that prototype signify a new structural lead for antileishmanial chemotherapy.

Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors

Kühne, Holger,Obst-Sander, Ulrike,Kuhn, Bernd,Conte, Aurelia,Ceccarelli, Simona M.,Neidhart, Werner,Rudolph, Markus G.,Ottaviani, Giorgio,Gasser, Rodolfo,So, Sung-Sau,Li, Shirley,Zhang, Xiaolei,Gao, Lin,Myers, Michael

, p. 5092 - 5097 (2016/10/05)

Dual inhibition of fatty acid binding proteins 4 and 5 (FABP4 and FABP5) is expected to provide beneficial effects on a number of metabolic parameters such as insulin sensitivity and blood glucose levels and should protect against atherosclerosis. Starting from a FABP4 selective focused screening hit, biostructure information was used to modulate the selectivity profile in the desired way and to design potent dual FABP4/5 inhibitors with good selectivity against FABP3. With very good pharmacokinetic properties and no major safety alerts, compound 12 was identified as a suitable tool compound for further in vivo investigations.

Poly(N-bromo-N-ethylbenzene-1,3-disulfonamide) and N,N,N′,N′-tetrabromobenzene-1,3-disulfonamide as efficient reagents for synthesis of quinolines

Ghorbani-Vaghei, Ramin,Akbari-Dadamahaleh, Somayeh

scheme or table, p. 1055 - 1058 (2009/05/11)

Poly(N-bromo-N-ethylbenzene-1,3-disulfonamide) [PBBS] and N,N,N′,N′-tetrabromobenzene-1,3-disulfonamide [TBBDA] were used as efficient reagents for the synthesis of quinolines in excellent yields from 2-aminoaryl ketones and carbonyl compounds under aqueo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 312758-85-3